跳至主要内容
临床试验/CTRI/2020/06/025773
CTRI/2020/06/025773尚未招募3 期

“EFFICACY OF MATRA BASTI AND SHASHTIKA SHALI PINDA SWEDA IN THE MANAGEMENT OF CEREBRAL PALSY - AN OPEN LABELLED, RANDOMIZED, COMPARATIVE CLINICAL TRIAL’’

Director IPGT and RAr1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年1月7日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
spasticity muscle power and general health condition assessment by specially prepared performa

研究概览

简要总结

This is an open labelled randomized comparative clinical trial to study the efficacy of Matra Basti and Shashtika Shali Pinda Sweda  ( A schedule of 8 days in which medicine will be given through anal route and special type of Sweadana will be done) in the management of cerebral palsy There are two groups for the study purpose In group A three sittings of Matra Basti will be carried out In group B Shashtika Shali Pinda Sweda will be carried out An interval between each sitting are 10 days. In both groups Medhya Churna (combination of dry powder of six herbal drugs) will be administered as an internal medicine throughout the treatment schedule of 74 days with Anupana ( vehicle or adjuvent) Madhu (Honey) Follow up period is 8 weeks for both the groups

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
6.00 Month(s) 至 10.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed children of cerebral Palsy of either sex of 6 month to 10 years of age Children with developmental disability both either physical or mental in mild or moderate degree as compare to other normal children.

排除标准

  • Children below 6 month of age and above 10 years Children of Cerebral Palsy with major congenital disorders.

结局指标

主要结局

spasticity muscle power and general health condition assessment by specially prepared performa

时间窗: 2 months

次要结局

  • assess quality of life BY special prepared performa(3 months)

研究者

发起方
Director IPGT and RAr
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验